Abstract
Abstract Fungal transformation of the diterpenoid kaempulchraol E (1) by Rhizopus oryzae KX685359 afforded two trihydroxlated isopimaradienes: 2α,6β,14β-trihydroxy-isopimara-8(9),15-diene (2) and 2α,6β,14α-trihydroxy-isopimara-8(9),15-diene (3) in addition to the known metabolite roscorane B (4). Chemical structures were established by spectroscopic techniques including: HRMS, FT-IR and 1D- & 2D-NMR. The structure of 2 was confirmed by single-crystal, X-ray diffraction analysis. Bio-transformed metabolites as well as the substrate originally isolated from Kaempheria galanga were tested against two cancer cell lines: HSC-2 and B16-BL6. Compounds 4 showed greater toxicity than the original plant derived diterpene (IC50 54.08 ± 0.05 versus 96.05 ± 0.03 μM, respectively) when assayed against the HSC-2 cell line. This study confirms the role of fungal transformations in developing novel natural products with efficacious biological activities.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
